| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/17/2008 | CN101322691A Naloxone hydrochloride nano granule powder injection formulation and preparation thereof |
| 12/17/2008 | CN101322689A Preparation of docetaxel long-circulating liposome and freeze-dried powder injection thereof |
| 12/17/2008 | CN101322688A Flumazenil oil-in-water emulsion for vein and preparation thereof |
| 12/17/2008 | CN101322687A Adenosine cyclophosphate oil in water composition for vein and preparation thereof |
| 12/17/2008 | CN101322686A Daimeton (sodium) suspension injection and preparation thereof |
| 12/17/2008 | CN101322685A Mezlocillin sodium and sulbactam sodium for injection and freeze-dried injection preparation thereof |
| 12/17/2008 | CN101322683A Gel for eye containing bromfenac sodium hydrate and preparation thereof |
| 12/17/2008 | CN101322681A Method for preparing nano micelle formulation of anthracene nucleus antineoplastic antibiotic |
| 12/17/2008 | CN101322574A Powdered beverage composition |
| 12/17/2008 | CN100443498C Use of anti-inflammatory medicine for scheelite total saponin and its saponin compound |
| 12/17/2008 | CN100443496C A-decarbon-5 alpha-androstane-2-one-17 beta-alcohol ester and its prepn and use |
| 12/17/2008 | CN100443495C Triterpene saponin compound of cycro jackfruit alkyl, and effect for anti tumor |
| 12/17/2008 | CN100443494C 2-phenoxy chromone heteroside compounds and its preparing method and use |
| 12/17/2008 | CN100443493C Process of preparing burdock glucoside and glucosidgen thereof |
| 12/17/2008 | CN100443487C N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 12/17/2008 | CN100443486C 7-esterified and 7,20-double esterified camptothecine derivant and method for preparing the same and pharmaceutical combination and uses thereof |
| 12/17/2008 | CN100443485C Derivative of soldium iron chlorophyllin, preparation method and application |
| 12/17/2008 | CN100443482C Benzofuran derivatives and their use in the treatment of microbial infections |
| 12/17/2008 | CN100443481C Imidazolyl-cyclic acetals |
| 12/17/2008 | CN100443480C Tricyclic compound and its preparation and use |
| 12/17/2008 | CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 12/17/2008 | CN100443477C Substituted benzoxazoles and analogues as estrogenic agents |
| 12/17/2008 | CN100443474C New pyridazin-3(2h)-one derivatives |
| 12/17/2008 | CN100443472C 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 12/17/2008 | CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/17/2008 | CN100443182C Preparation method of light coloured high purity sodium polystyrenesulfonate cation exchange resin |
| 12/17/2008 | CN100443119C Inhalation of nitric oxide |
| 12/17/2008 | CN100443118C Dosages for treatment with anti-ErbB2 antibodies |
| 12/17/2008 | CN100443115C Granule with beauty and health function |
| 12/17/2008 | CN100443113C Anshenbunao granule and its preparation method |
| 12/17/2008 | CN100443092C Granulocyte raised drug comprising cepharanthine |
| 12/17/2008 | CN100443090C Chinese traditional medicine for treating coronary heart disease |
| 12/17/2008 | CN100443088C Medicinal preparation for treating gynecologic blood diseases and inflammation |
| 12/17/2008 | CN100443087C Transdermal absorptive preparation of pennogenin compounds |
| 12/17/2008 | CN100443086C New use of ginseng saponin-Re medicine and its preparation method |
| 12/17/2008 | CN100443085C Externally applied compound gel and its preparing method |
| 12/17/2008 | CN100443084C Alprostadil preparation and its making method |
| 12/17/2008 | CN100443083C Use of aconine in medicine manufacture |
| 12/17/2008 | CN100443082C Bilogical adhesive tablet of ornidazole and method for preparing the same |
| 12/17/2008 | CN100443081C Combination of sweet-scented osmanthus and plantinum chemotherapeutic medicine |
| 12/17/2008 | CN100443080C Medicinal composition for preventing and treating cancer diseases |
| 12/17/2008 | CN100443079C Method for fabricating preparation of del for anesthesia and analgesia on surface of skin |
| 12/17/2008 | CN100443078C Gel for local anesthesia and analgesia on surface of skin, and usage |
| 12/17/2008 | CN100443077C Composition comprising cysteamine for improving lactation in dairy animals |
| 12/16/2008 | US7465836 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 12/16/2008 | US7465831 Levalbuterol hydrochloride Polymorph A |
| 12/16/2008 | US7465829 N-halo-4-carboxybenzene sulfonamides; soap, lotion, wipe, or swab; minimal side effects; bactericide, pesticide, fungicide, deodorizing; also bovine teat cleaners, drugs for cultured fish, soap biocides, stain removal agents, and paint fungicides |
| 12/16/2008 | US7465820 Abiotic heparin antagonists |
| 12/16/2008 | US7465817 Inositolized phospholipids |
| 12/16/2008 | US7465815 Cannabinoid receptor modulator |
| 12/16/2008 | US7465811 [3-[[[[2,3-dihydro-1-[[3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]sulfonyl]-1H-indol-2-yl]carbonyl]amino]methyl]phenoxy]acetic acid methyl ester; retinoic acid, farnesoid X, peroxisome proliferator-activated receptors modulator; antiinflammatory, antidiabetic agent, atherosclerosis, Alzheimer's disease |
| 12/16/2008 | US7465808 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionic acid and Na salt; 3-[5-Benzo[1,3]dioxol-5-yl-1-(2,5-dichloro-phenyl)-1H-pyrazol-3-yl]-2-(3-chloro-phenyl)-acrylic acid; 5-{(S)-2-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-pyrazol-3-yl]-1-m-tolyl-ethyl}-1H-tetrazole |
| 12/16/2008 | US7465805 Isoxazoline derivatives and their use as herbicides |
| 12/16/2008 | US7465803 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 12/16/2008 | US7465800 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 12/16/2008 | US7465799 Methods and compositions for selectin inhibition |
| 12/16/2008 | US7465798 Methods and compositions for selectin inhibition |
| 12/16/2008 | US7465795 Compounds and uses thereof |
| 12/16/2008 | US7465766 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 12/16/2008 | US7465756 Bronchodilating beta-agonist compositions and methods |
| 12/16/2008 | US7465755 4-(2-{1-acetyl-2-[4-(3-chlorophenyl)-3-hydroxybutyl]hydrazino}ethyl)benzoic acid; prostaglandin EP2 and/or EP4 receptors; respiratory, inflammatory, sexual disorders, osteoporosis, ulcers; reductive amination, Michael addition, saponification |
| 12/16/2008 | US7465754 Using cytokine inducer [R-(R*,R*)]-N-[(R)-6-carboxy-N2-[[2-carboxy-1-methyl-2-[(1-oxoheptyl)amino]-ethoxy]carbonyl]-L-lysyl]-alanine and chemotherapeutic agent paclitaxel or a combination of paclitaxel and carboplatin for therapy of non-small cell lung tumor |
| 12/16/2008 | US7465753 hydrophobic drug having (a) glycoside like GlcNAc-Gal-, GlcNAc-Gal-Glc-, Fuc-Gal-, Gal-Glc-, as sugar moiety (b) phosphatidylcholines (c) stearylamine or oleylamine; composition improves the low solubility of gylcoside; cholestenol glycoside anticancer drug; improved drug delivery |
| 12/16/2008 | US7465752 Peroxisome Proliferator Activated Receptors modulators; ethyl (R,S)-2-(4-trifluoromethylphenyl)oxypent-4-enoate; dyslipidemia, atherosclerosis and diabetes |
| 12/16/2008 | US7465751 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency |
| 12/16/2008 | US7465750 Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods |
| 12/16/2008 | US7465749 The impurity isoletrozole is more rapidly oxidized to 4,4'-dicyanobenzophenone than Letrozole, which can be seperated by crystallization to yield highly purified letrozole |
| 12/16/2008 | US7465748 Amide derivative |
| 12/16/2008 | US7465747 Fluorescent label compounds |
| 12/16/2008 | US7465746 Fluorinated 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP |
| 12/16/2008 | US7465745 Cathepsin S inhibitors |
| 12/16/2008 | US7465744 Triazole compounds and the therapeutic use thereof |
| 12/16/2008 | US7465743 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors |
| 12/16/2008 | US7465742 Heterocyclic compounds having anti-HBV activity |
| 12/16/2008 | US7465741 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative |
| 12/16/2008 | US7465740 2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists |
| 12/16/2008 | US7465739 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes |
| 12/16/2008 | US7465738 Gene for spinal muscular atrophy |
| 12/16/2008 | US7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 12/16/2008 | US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 12/16/2008 | US7465735 crop protection agents for controlling harmful fungi; improved activity; 6-chloro-2-(N'-isopropylidene-hydrazino)-5-(2,4,6-trifluorophenyl)pyrimidine-4-yl]-((S)-1-trifluoromethylethyl)amine; against Septoria Leaf Blotch of Wheat, Net Blotch of Barley and Mildew of Cucumber |
| 12/16/2008 | US7465734 Detecting potential therapeutic agent |
| 12/16/2008 | US7465733 trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders |
| 12/16/2008 | US7465732 (2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives |
| 12/16/2008 | US7465731 HDAC inhibitor |
| 12/16/2008 | US7465730 Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds |
| 12/16/2008 | US7465729 Methods of treatment of menopause and perimenopause using eszopiclone |
| 12/16/2008 | US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 12/16/2008 | US7465727 e.g. 4-[2-(4-Diethylaminomethyl-phenyl)-1,9b-dihydro-5-oxa-3,3a-diaza-cyclopenta[a]-naphthalene-4-carbonyl]-benzonitrile; AIDS and HIV multidrug resistantce; inhibitors of the viral replication of the HIV virus opposed to inhibitors of reverse transcriptase (RT) or protease |
| 12/16/2008 | US7465726 Substituted pyrrolo[2.3-B]pyridines |
| 12/16/2008 | US7465725 e.g. N-{2-[3-(3,4-dimethoxy-phenyl)-propyl]-6-morpholin-4-yl-pyrimidin-4-yl}-N'-(1H-indol-3-ylmethylene)-hydrazine; interleukin-12 antagonist; antiinflammatory, antidiabetic agent; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus |
| 12/16/2008 | US7465724 e.g. 1,4-bis-{3-[7-methoxy-8-oxy-(11aS)-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one]propyloxy}anthracene-9,10-dione; antitumor agent; lung, cervix, breast, colon, prostate and ovary cancer cell lines |
| 12/16/2008 | US7465723 Use of carboxamides for the treatment of tinnitus |
| 12/16/2008 | US7465722 Biphenyl vasopressin agonists |
| 12/16/2008 | US7465721 N-(10H-phenothiazin-2-ylcarbonyl)-L-leucyl-L-leucyl-N1-[(3 S)-2-methoxytetrahydrofuran-3-yl]-L-leucinamide; calpain (proteolytic enzyme) inhibitor; traps the reactive oxygen species ; antiinflammatory, antiproliferative agent, autoimmune diseases |
| 12/16/2008 | US7465720 Proteasome inhibiting β-lactam compounds |
| 12/16/2008 | US7465719 e.g. 4-{[(Benzyloxy)amino]carbonyl}phenyl 1-(4-methoxyphenyl)cyclohexanecarboxylate; histone deacetylase inhibitor; anticarcinogenic, antiproliferative agent; neurodegenerative diseases; bactericide; psoriasis, osteoarthritis; rheumatoid arthritis, malaria, protozoal infection, Alzheimer's; Parkinson's |
| 12/16/2008 | US7465718 Ansamycins having improved pharmacological and biological properties |
| 12/16/2008 | US7465717 Process for releasing and extracting phosphatides from a phosphatide-containing matrix |
| 12/16/2008 | US7465716 Targeted drug delivery with a hyaluronan ligand |